Clinical Trials Browser

Phase 1/2 × Hematologic Neoplasms × Etanercept × Clear all

NCT04082910 2022-04-13

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Phase 1/2 Unknown

Other hematologic neoplasm

Cytokine Release Syndrome, Hematologic Neoplasms